Pharmacokinetics of Acetaminophen in Morbidly Obese Patients
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study will investigate the pharmacokinetics of acetaminophen in morbidly obese patients
versus normal weight patients. Specifically the different metabolic pathways of acetaminophen
in morbidly obese adults will be investigated; glucuronidation, sulphation and CYP2E1
(cytochrome P450 2E1) oxidation